Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Moma Therapeutics
Biotech
MBX Biosciences, MaaT Pharma and more—Chutes & Ladders
Metabolic disorder biotech lands industry vet as CMO. MaaT welcomes ex-Autolus leader. Former Seagen execs take Shape.
Gabrielle Masson
,
Andrea Park
Jun 28, 2024 8:30am
Another Biogen exec hitches ride to Voyager —Chutes & Ladders
Mar 15, 2024 9:30am
Moma’s the word as Roche signs $2B deal to develop cancer drugs
Jan 4, 2024 7:00am
Big Pharmas shield BigHat from stormy market with $75M funding
Jul 20, 2022 8:00am
$1.1B fund at Third Rock Ventures will go to 10 new biotechs
Jun 15, 2022 6:30am
Moma Therapeutics raises $150M for precision cancer medicines
May 10, 2022 7:00am
